ESMO WCGC 2013 Report – Hot topics in Colon Cancer
Written by Lorraine Carolan | 12 Sep 2013
by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.
ESMO WCGC 2013 – Video Interview with Prof. Lenz
Written by Lorraine Carolan | 11 Sep 2013
We ask Professor Heinz-Josef Lenz, Professor of Medicine, Associate Director Clinical Research what he thinks is going to be the next big thing in colorectal cancer for the… read more.
90% of dementia undetected in China
Written by Gary Finnegan | 11 Sep 2013
World Health Matters by Gary Finnegan – China – An international team of scientists has found that over 90% of dementia cases in China go undetected, with the… read more.
Diet counteracts genetic stroke risk
Written by Gary Finnegan | 10 Sep 2013
World Health Matters by Gary Finnegan – Spain – A gene variant strongly associated with the development of type 2 diabetes appears to interact with a Mediterranean diet… read more.
Handful of doctors attract bulk of patient complaints
Written by Gary Finnegan | 9 Sep 2013
World Health Matters – Australia – by Gary Finnegan – Half of all formal complaints made to health ombudsmen in Australia concern just 3% of the country’s doctors,… read more.
Could a blood test predict suicide risk?
Written by Gary Finnegan | 6 Sep 2013
World Health Matters by Gary Finnegan – United States – A series of RNA biomarkers have been found which researchers say could help to identify people at risk… read more.
Green light for new medicines
Written by Gary Finnegan | 5 Sep 2013
EMA Highlights by Gary Finnegan – The EMA’s Committee for Medicinal Products for Human Use (CHMP) has a new member: Ivana Mikacic has been nominated by Croatia which… read more.
Health professionals get stronger say
Written by Gary Finnegan | 4 Sep 2013
EMA Highlights by Gary Finnegan – A new Healthcare Professionals’ Working Party (HCPWP) has been created by the European Medicines Agency in an effort to secure greater input… read more.
Trial data row puts regulator on the spot
Written by Gary Finnegan | 3 Sep 2013
EMA Highlights by Gary Finnegan – The European Medicines Agency (EMA) must perform a delicate balancing act as it finds itself centre stage in the on-going debate about… read more.
Ketamine shows antidepressant effect in refractory depression
Written by Bruce Sylvester | 2 Sep 2013
FDA Highlights by Bruce Sylvester – Researchers report that, in a double-blind trial involving clinically depressed patients who had not responded to at least three prior antidepressants, intravenous… read more.
Haloperidol does not reduce delirium in critically ill patients
Written by Bruce Sylvester | 30 Aug 2013
FDA Highlights by Bruce Sylvester – Treatment with the antipsycotic drug haloperidol does not reduce symptoms of delirium in critically ill patients, UK researchers report.
Chemotherapy-refractory large B-cell lymphomas reprogrammed to respond to Azacitidine
Written by Bruce Sylvester | 29 Aug 2013
FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
